Mutations in PIK3CA sensitize breast cancer cells to physiologic levels of aspirinSanja Turturro(Rush University Medical Center), Abde M. Abukhdeir(Rush University Medical Center)Breast Cancer Research and TreatmentFebruary 1, 201610.1007/s10549-016-3729-8Cited by 24SaveCiteExport RISWatch citationsRelated PapersKnock in of the AKT1 E17K mutation in human breast epithelial cells does not recapitulate oncogenic PIK3CA mutations|Oncogene|2010|58